Taysha Gene TherapiesTSHA
那斯達克 · USD
2.63
-0.10
(-3.66%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Taysha Gene TherapiesTSHA
2.63
-0.10
(-3.66%)
財務數據
損益表
- 0.03
- 0.05
- 0.02
- 0.05
- 0.04
- 0.03
- 0.01
- 0.02
- 0.02
- 0.02
- -
- 88.09
- -49.11
- 98.16
- -24.06
- -5.36
- -67.40
- 60.79
- 13.09
- 13.85
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 2,302 | 2,022 | 1,788 | 1,112 | 3,411 | 3,604 | 4,746 | 2,395 | 4,706 | 2,502 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 2,302 | 2,022 | 1,788 | 1,112 | 3,411 | 3,604 | 4,746 | 2,395 | 4,706 | 2,502 |
營業費用 | 23,723 | 21,954 | 27,686 | 22,411 | - | 19,850 | 20,996 | 25,779 | 21,265 | 56,468 |
研發費用 | 15,565 | 15,325 | 14,946 | 15,073 | 20,657 | 12,682 | 11,791 | 19,791 | 12,514 | 12,707 |
推銷及管理費用 | 8,158 | 6,629 | 7,902 | 7,338 | 7,084 | 6,719 | 8,589 | 5,988 | 8,751 | 7,341 |
非經常性項目費用 | - | - | 4,838 | - | - | 449 | 616 | - | - | 36,420 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,421 | -19,932 | -25,898 | -21,299 | -24,330 | -16,246 | -16,250 | -23,384 | -16,559 | -53,966 |
其他收入及費用 | -89 | 1,169 | 398 | 398 | 298 | 64,700 | -99,366 | 226 | 311 | 193 |
利息費用 | 19 | 22 | 24 | 27 | 29 | 713 | 1,471 | 1,440 | 1,374 | 1,305 |
稅前純益 | -21,529 | -18,785 | -25,524 | -20,928 | -24,061 | 47,741 | -117,087 | -24,598 | -17,622 | -55,078 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -21,529 | -18,785 | -25,524 | -20,928 | -24,061 | 47,741 | -117,087 | -24,598 | -17,622 | -55,078 |
基本每股稅後盈餘(元) | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | - | -0.93 | -0.38 | -0.28 | -0.99 |
稀釋每股稅後盈餘(元) | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | 0.92 | -1.22 | -0.38 | -0.28 | -0.99 |
基本平均股數(千股) | 269306.00 | 268643.00 | 267824.00 | 232821.00 | 231249.00 | - | 125700.00 | 64244.00 | 63260.00 | 56386.00 |
稀釋平均股數(千股) | 269306.00 | 268643.00 | 267824.00 | 232821.00 | 231249.00 | - | 125700.00 | 64244.00 | 63260.00 | 56386.00 |
還原基本每股稅後盈餘(元) | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | - | -0.93 | -0.38 | -0.28 | -0.99 |
還原稀釋每股稅後盈餘(元) | -0.08 | -0.07 | -0.10 | -0.09 | -0.10 | 0.92 | -1.22 | -0.38 | -0.28 | -0.99 |
還原基本平均股數(千股) | 269,306 | 268,643 | 267,824 | 232,821 | 231,249 | - | 125,700 | 64,244 | 63,260 | 56,386 |
還原稀釋平均股數(千股) | 269,306 | 268,643 | 267,824 | 232,821 | 231,249 | - | 125,700 | 64,244 | 63,260 | 56,386 |
EBITDA(千元) | -21,227 | -18,459 | -25,206 | -20,579 | -23,707 | 48,820 | -115,285 | -22,815 | -15,917 | -53,411 |